Elastography imaging market seen topping $6.4 billion by 2030

The global elastography imaging market is projected to grow from $4.27 billion in 2026 to $6.41 billion by 2030, driven by demand for non-invasive diagnostics, AI-assisted analysis and broader use in oncology and cardiology. Asia-Pacific led the market in 2025 as chronic liver disease and breast cancer cases kept boosting clinical demand.

Why it matters: - Elastography imaging is becoming a more important tool for diagnosing disease without invasive procedures. - The market's growth reflects rising demand for earlier detection, better tissue assessment and wider access to advanced imaging. - Expanding use in liver disease, oncology and cardiology could broaden the technology's role in routine care.

What happened: - The Business Research Company published The Business Research Company's Elastography Imaging Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Aug. 5, 2026. - The report estimates the elastography imaging market will rise from $3.87 billion in 2025 to $4.27 billion in 2026. - The report projects the market will reach $6.41 billion by 2030. - The company said the market's 2026-2030 CAGR will be 10.7%. - Asia-Pacific held the largest market share in 2025. - The report covers South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full report.

The details: - Elastography imaging measures tissue and organ stiffness through non-invasive, low-frequency vibrations. - The method helps clinicians assess conditions where tissue rigidity changes. - Growth in 2025 and 2026 has been driven by higher rates of liver and musculoskeletal disease. - Expanded availability of diagnostic imaging services has supported adoption. - Broader use of ultrasound-based diagnostic techniques has also contributed to demand. - Clinical recognition of tissue stiffness evaluation has increased. - Access to advanced imaging technologies has improved market uptake. - Chronic liver diseases and breast cancer are major growth drivers. - In hepatology, elastography is used to measure liver stiffness and support chronic liver disease management. - The American Cancer Society reported in January 2023 that new cases of liver and intrahepatic bile duct cancer among US females reached 13,230. - The report highlights wider adoption of shear wave elastography. - Integration of elastography with ultrasound platforms is a key trend. - The market is diversifying into multi-organ diagnostics. - Early-stage disease identification is receiving greater emphasis.

Between the lines: - The market is shifting from a specialized imaging approach toward broader clinical use across multiple specialties. - AI-assisted image analysis and non-invasive diagnostics point to a push for faster, more accessible screening and follow-up care. - Asia-Pacific's lead suggests uneven adoption, with some regions moving faster as imaging infrastructure improves.

What's next: - The report expects stronger demand as investment in imaging infrastructure rises. - Growth is likely to track continued adoption of AI tools and non-invasive diagnostic methods. - Future expansion may depend on how quickly elastography moves into more multi-organ and specialty workflows. - The company's 2026 report package includes TAM analysis, company scoring matrices, forecasting dashboards, market hotspots infographics and updated graphics and tables. - The Business Research Company lists Saumya Sahay as a contact for expert inquiries.